Comparison of scales for evaluating premenstrual symptoms in women using oral contraceptives

Pharmacotherapy

Volumn 28, Issue 5 PART 1, 2008, Pages 576-583

  Coffee, Andrea L ^a,b   Kuehl, Thomas J ^a   Sulak, Patricia J ^a  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

Mood; Oral contraceptives; Penn state daily symptom report; PMS; Premenstrual symptoms; Scott white daily diary of symptoms

Indexed keywords

DROSPIRENONE PLUS ETHINYLESTRADIOL;

ADULT; ANXIETY; ARTICLE; CORRELATION COEFFICIENT; DATA ANALYSIS; DEPRESSION; FEMALE; HEADACHE; HUMAN; INTERMETHOD COMPARISON; IRRITABILITY; MAJOR CLINICAL STUDY; MOOD; ORAL CONTRACEPTION; PELVIS PAIN SYNDROME; PENN STATE DAILY SYMPTOM REPORT; PREMENSTRUAL SYNDROME; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SCOTT AND WHITE DAILY DIARY OF SYMPTOMS; SYMPTOM; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; AFFECT; ALDOSTERONE ANTAGONISTS; ANDROSTENES; CONTRACEPTIVES, ORAL, COMBINED; CONTRACEPTIVES, ORAL, HORMONAL; DRUG COMBINATIONS; ESTROGENS; ETHINYL ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; PREMENSTRUAL SYNDROME; QUESTIONNAIRES; WEIGHTS AND MEASURES;

EID: 42949114014     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.5.576     Document Type: Article

References (14)

1. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl, TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet Gynecol 2000;95(2):261-6.
2. American College of Obstetricians and Gynecologists. Premenstrual syndrome. ACOG Pract Bull 2000;15:1-8.
3. First MB, ed. Premenstrual dysphoric disorder. In: Diagnostic and statistical manual, fourth edition, text revision (DSM-IV-TR). Washington, DC; American Psychiatric Association, 2000:771-4.
4. Moos RH. The development of a menstrual distress questionnaire. Psychosom Med 1968;30(6):853-67.
5. Steiner M, Haskett RF, Carroll BJ. Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 1980;62(2):177-90.
6. Feuerstein M, Shaw WS. Measurement properties of the calendar of premenstrual experience in patients with premenstrual syndrome. J Reprod Med 2002;47(4):279-89.
7. Endicott J, Nee J, Harrison W. Daily record of severity of problems (DRSP): reliability and validity. Arch Women Ment Health 2006;9(1):41-9.
8. Steiner M, Steinberg S, Stewart D, et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian fluoxetine/premenstrual dysphoria collaborative study group. N Engl J Med 1995;332(23):1529-34.
9. Steiner M, Streiner DL, Steinberg S, et al. The measurement of premenstrual mood symptoms. J Affect Disord 1999;53(3):269-73.
10. Sulak PJ, Kuehl TJ, Coffee A, Willis S. Prospective analysis of occurrence and management of breakthrough bleeding during an extended oral contraceptive regimen. Am J Obstet Gynecol 2006;195(4):935-41.
11. Coffee AL, Kuehl TJ, Willis S, Sulak PJ. Oral contraceptives and premenstrual symptoms: comparison of a 21/7 and extended regimen. Am J Obstet Gynecol 2006;195(5):1311-19.
12. Sulak PJ, Willis S, Kuehl T, Coffee A, Clark J. Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 2007;47(1):27-37.
13. Batra P, Harper DM. Recognizing and treating premenstrual dysphoric disorder. J Clin Outcomes Manage 2002;9:87-98.
14. Freeman EW, DeRubeis RJ, Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Res 1996;65:97-106.